P1 reagents are now available for NextSeq 1000 and NextSeq 2000 Systems, offering added flexibility to meet your project's needs
Order NowEnable comprehensive genomic profiling with accurate and comprehensive homologous recombination deficiency assessment
Learn MoreLearn about the latest genomics discoveries by Illumina scientists, or find webinars and free courses to get the most out of your experiments
Explore Discoveries View Webinars View CoursesFilter by microbiology, cancer research, and more. Compare and cart products.
Find the Right Kit
On National Intern Day, Illumina’s interns share their advice and experiences
Read Article| Date | Publication | Title |
|---|---|---|
| Jul 13, 2022 | Business Weekly | Ovarian cancer pioneer builds on Illumina Accelerator success |
| Jun 28, 2022 | CSR Egypt | Illumina hails Egypt’s aspirations for utilizing genomics in healthcare issues |
| Jun 28, 2022 | Genome Web | Illumina Invests in UK-Based Genomics Venture Fund Tied to Startup Accelerator Program |